Camilo Henrique S Lima

17PUBLICATIONS
62CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsBiomolecular modelling and designProteins and peptidesCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Oct 08, 2026
Synergistic Cytotoxicity of Cafestol and Kahweol With Doxorubicin in Breast Cancer Cells Involves TNF‑α Targeting and NF‑κB Downregulation.

|Jan 26, 2026
Machine Learning and Molecular Modeling for Drug Repurposing Targeting Potential PI3Kα Inhibitors in Post-CoViD-19 Pulmonary Fibrosis.

Carine Ribeiro Dos Santos, Priscila Goes Camargo, Carlos Rangel Rodrigues

|Jul 20, 2025
Statine-based peptidomimetics as SARS-CoV-2 Papain-like protease inhibitors: in Silico and in vitro studies.

Raiane Dandara Pereira Pimentel, Priscila Goes Camargo, Pedro Henrique R de A Azevedo

|Jun 09, 2025
Molecular Modeling and In Vitro Evaluation of Thioureas and Arylthioureas as Urease Inhibitors.

Marciéli Fabris, Priscila G Camargo, Mariana L Silva

|May 12, 2025
Molecular Dynamics Studies on Trypanosoma cruzi Dihydroorotate Dehydrogenase Complexes: An Analysis of the Inhibitor Influence.

Eldio G Santos, Luiz A P Flores-Junior, Camilo H S Lima

|Feb 19, 2025
In silico evaluation of N-aryl-1,10-phenanthroline-2-amines as potential inhibitors of T. cruzi GP63 zinc-metalloprotease by docking and molecular dynamics simulations.

Priscila Goes Camargo, Ramon Borges da Silva, Aline Araujo Zuma

Pageof 3

Frequent Collaborators

10 joint publications

Priscila Goes Camargo

9 joint publications

Marcelle L F Bispo

7 joint publications

Magaly Girão Albuquerque

5 joint publications

Kaio Maciel de Santiago-Silva